Sichuan Lutianhua Company Limited By Shares Résultats passés
Passé contrôle des critères 1/6
Sichuan Lutianhua Company Limited By Shares's earnings have been declining at an average annual rate of -13.5%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 3.6% per year. Sichuan Lutianhua Company Limited By Shares's return on equity is 0.6%, and it has net margins of 0.7%.
Informations clés
-13.5%
Taux de croissance des bénéfices
-14.7%
Taux de croissance du BPA
| Chemicals Croissance de l'industrie | 12.1% |
| Taux de croissance des recettes | 3.6% |
| Rendement des fonds propres | 0.6% |
| Marge nette | 0.7% |
| Dernière mise à jour des bénéfices | 30 Sep 2024 |
Mises à jour récentes des performances passées
Recent updates
Is Sichuan Lutianhua Company Limited By Shares (SZSE:000912) A Risky Investment?
Oct 16
Sichuan Lutianhua Company Limited By Shares' (SZSE:000912) Business Is Trailing The Market But Its Shares Aren't
Sep 24There May Be Some Bright Spots In Sichuan Lutianhua Company Limited By Shares' (SZSE:000912) Earnings
Sep 02Improved Revenues Required Before Sichuan Lutianhua Company Limited By Shares (SZSE:000912) Shares Find Their Feet
Jun 05Here's What's Concerning About Sichuan Lutianhua Company Limited By Shares' (SZSE:000912) Returns On Capital
Apr 17Here's Why Sichuan Lutianhua Company Limited By Shares (SZSE:000912) Can Manage Its Debt Responsibly
Mar 26Sichuan Lutianhua Company Limited By Shares' (SZSE:000912) Low P/E No Reason For Excitement
Mar 05Ventilation des recettes et des dépenses
Comment Sichuan Lutianhua Company Limited By Shares gagne et dépense de l'argent. Sur la base des derniers bénéfices déclarés, sur une base LTM.
Historique des gains et des recettes
| Date | Recettes | Les revenus | Dépenses G+A | Dépenses de R&D |
|---|---|---|---|---|
| 30 Sep 24 | 5,312 | 39 | 349 | 71 |
| 30 Jun 24 | 5,641 | 130 | 347 | 82 |
| 31 Mar 24 | 5,520 | 10 | 333 | 81 |
| 31 Dec 23 | 6,418 | 150 | 351 | 79 |
| 30 Sep 23 | 7,341 | 262 | 389 | 81 |
| 30 Jun 23 | 7,035 | 175 | 380 | 78 |
| 31 Mar 23 | 7,974 | 401 | 439 | 81 |
| 01 Jan 23 | 7,534 | 367 | 420 | 77 |
| 30 Sep 22 | 7,328 | 334 | 498 | 26 |
| 30 Jun 22 | 7,721 | 484 | 503 | 42 |
| 31 Mar 22 | 7,368 | 536 | 432 | 38 |
| 01 Jan 22 | 6,753 | 446 | 420 | 37 |
| 30 Sep 21 | 6,552 | 656 | 439 | 44 |
| 30 Jun 21 | 5,975 | 579 | 318 | 15 |
| 31 Mar 21 | 5,380 | 397 | 304 | 31 |
| 31 Dec 20 | 5,618 | 381 | 298 | 27 |
| 30 Sep 20 | 5,171 | 257 | 232 | 31 |
| 30 Jun 20 | 5,563 | 290 | 285 | 23 |
| 31 Mar 20 | 5,634 | 287 | 266 | 1 |
| 31 Dec 19 | 5,507 | 283 | 287 | 3 |
| 30 Sep 19 | 5,356 | 177 | 338 | 5 |
| 30 Jun 19 | 5,040 | 187 | 274 | 8 |
| 31 Mar 19 | 4,767 | 296 | 366 | 8 |
| 31 Dec 18 | 4,405 | 352 | 333 | 5 |
| 30 Sep 18 | 4,200 | -990 | 298 | 5 |
| 30 Jun 18 | 3,973 | -1,180 | 303 | 3 |
| 31 Mar 18 | 3,805 | -1,402 | 252 | 3 |
| 31 Dec 17 | 3,735 | -1,488 | 237 | 3 |
| 30 Sep 17 | 3,706 | -380 | 276 | 0 |
| 30 Jun 17 | 3,492 | -493 | 305 | 0 |
| 31 Mar 17 | 3,210 | -596 | 299 | 0 |
| 31 Dec 16 | 3,059 | -637 | 304 | 0 |
| 30 Sep 16 | 1,825 | -311 | 271 | 0 |
| 30 Jun 16 | 1,875 | -94 | 210 | 0 |
| 31 Mar 16 | 2,420 | 22 | 300 | 0 |
| 31 Dec 15 | 3,028 | 18 | 305 | 0 |
| 30 Sep 15 | 4,045 | -839 | 465 | 0 |
| 30 Jun 15 | 4,417 | -997 | 519 | 0 |
| 31 Mar 15 | 4,452 | -1,101 | 466 | 0 |
| 31 Dec 14 | 4,004 | -1,141 | 469 | 0 |
| 30 Sep 14 | 3,651 | -601 | 377 | 0 |
| 30 Jun 14 | 3,829 | -500 | 393 | 0 |
| 31 Mar 14 | 4,072 | -386 | 381 | 0 |
| 31 Dec 13 | 4,071 | -298 | 405 | 0 |
Des revenus de qualité: 000912 has a large one-off loss of CN¥77.1M impacting its last 12 months of financial results to 30th September, 2024.
Augmentation de la marge bénéficiaire: 000912's current net profit margins (0.7%) are lower than last year (3.6%).
Analyse des flux de trésorerie disponibles par rapport aux bénéfices
Analyse de la croissance passée des bénéfices
Tendance des revenus: 000912 has become profitable over the past 5 years, growing earnings by -13.5% per year.
Accélération de la croissance: 000912's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Bénéfices par rapport au secteur d'activité: 000912 had negative earnings growth (-85.1%) over the past year, making it difficult to compare to the Chemicals industry average (-3.8%).
Rendement des fonds propres
ROE élevé: 000912's Return on Equity (0.6%) is considered low.